Pomerantz LLP is investigating potential claims against Zscaler, Inc. on behalf of investors concerning possible violations of federal securities laws. The investigation focuses on whether Zscaler and certain of its officers and/or directors engaged in securities fraud or other unlawful business practices. This scrutiny follows a significant decline in the company's stock price, which represents the steepest single-day drop since Zscaler went public.

On May 26, 2026, Zscaler reported its financial results for the third quarter of its 2026 fiscal year. Although the company's revenue and earnings exceeded expectations, it issued weaker-than-expected guidance and disclosed disruptions tied to sales leadership changes. Zscaler guided for revenue of between $875 million to $878 million, falling short of the $879 million consensus expectation.

Following this news, Zscaler's stock price fell $58.19, or 31.52%, to close at $126.41 per share on May 27, 2026. The investigation concerns whether Zscaler misled investors regarding its growth outlook, sales execution, customer expansion trends, and the impact of sales leadership changes before issuing the guidance.

Investors who purchased Zscaler securities and suffered losses are encouraged to contact Danielle Peyton at Pomerantz LLP at 646-581-9980, ext. 7980, or via email at newaction@pomlaw.com to evaluate their options. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as a premier firm in the areas of corporate, securities, and antitrust class litigation.

Zscaler and Amazon Web Services (AWS) have announced a strategic partnership to secure generative AI (GenAI) applications across the government, healthcare, and education sectors. The collaboration aims to address the unique security challenges faced by these industries as they adopt GenAI technologies.

The partnership will leverage Zscaler's cloud security platform and AWS's infrastructure to provide a secure environment for GenAI workloads. By integrating Zscaler's Zero Trust Exchange with AWS's cloud services, the companies intend to protect sensitive data and ensure compliance with industry regulations.

Key Objectives of the Partnership

• Enhance security for GenAI applications in highly regulated sectors.
• Protect sensitive data in government, healthcare, and education.
• Ensure compliance with industry-specific regulations.
• Provide a scalable and secure cloud infrastructure for GenAI deployments.

Sector-Specific Benefits

The partnership focuses on delivering tailored security solutions for each sector. In government, the emphasis is on protecting national security data and ensuring compliance with federal regulations. For healthcare, the priority is securing patient data and meeting HIPAA requirements. In education, the collaboration aims to protect student information and enable secure remote learning environments.

By combining their expertise, Zscaler and AWS seek to enable organizations in these sectors to harness the power of GenAI while maintaining robust security postures.